23 Feb Precision BioSciences
Posted at 19:31h
in
Cindy Atwell, Chief Development Officer and Chief Business Officer
Durham, NC
(NASDAQ: DTIL)
Precision BioSciences, Inc. (Nasdaq: DTIL), is a clinical stage biotechnology company dedicated to improving life (DTIL) with its novel and proprietary ARCUS® genome editing platform. ARCUS is a highly specific and versatile genome editing platform designed with therapeutic safety, delivery, and control in mind. Using ARCUS, Precision is developing in vivo gene correction therapies for infectious diseases as well as rare diseases.